Skip to textbook content
Doctor’s PassportTextbook
QuestionsFlashcardsBriefsDashboardAccount
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Psychiatry indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Serotonin syndrome and anticholinergic toxicity

Psychiatry · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Toxic agitation with hyperthermia

Rapidly rising temperature, marked rigidity or clonus, seizures, severe agitation, reduced consciousness or cardiovascular instability can signal life-threatening poisoning.

Action: Stop suspected causative drugs, call senior emergency and critical-care support, assess ABCDE and glucose, begin active supportive treatment and obtain TOXBASE or NPIS advice for the identified and possible co-ingestants.

Overview

Differentiate two potentially dangerous drug-induced syndromes through exposure history and examination, stop causative medicines and arrange monitored toxicological treatment with appropriate escalation.

Serotonin syndrome is better understood as a spectrum of toxicity than an all-or-nothing reaction. Mild tremor or restlessness may progress to clonus, marked autonomic activation, rigidity and dangerous hyperthermia. It can follow overdose, but interactions or therapeutic changes can also produce illness. Relevant exposures include serotonergic antidepressants, monoamine oxidase inhibition, some analgesics and certain recreational substances. Establish the sequence and look for combinations rather than assuming a familiar prescribed dose is always safe.

The examination is central. Assess mental state and autonomic observations, then look for spontaneous, inducible or ocular clonus, hyperreflexia, tremor and increased tone. Findings may be more conspicuous in the lower limbs, although advanced rigidity can make reflexes difficult to elicit. In a patient with serotonergic exposure, the Hunter criteria provide a structured combination of these features. They support clinical diagnosis but must not replace assessment for infection, neurological disease or mixed poisoning.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
PsychiatryOriginal SBA

Clonus after a new interaction

A patient taking sertraline develops agitation, sweating, diarrhoea, inducible ankle clonus and hyperreflexia after linezolid is started. Which syndrome best fits the exposure and examination?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Psychiatry topics →
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • NHS Greater Glasgow and Clyde serotonin syndrome guidanceClinical features, differential diagnosis and supportive management.
  • NHS Lanarkshire adult serotonin syndrome guideline October 2025Current regional guidance, review due October 2028; enteral cyproheptadine regimen and maximum with specialist toxicology confirmation.
  • NPIS TOXBASE serviceAgent-specific treatment, antidote selection and mixed poisoning advice.
  • NHS SPS poisoning and toxicity decision resourcesChoosing authoritative UK toxicology information and expert support.
  • University of Utah Poison Control antimuscarinic antidote safetySpecialist poison-centre safety explanation for conduction abnormalities and physostigmine; used for mechanism and precautions, not a UK dosing policy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·

Anticholinergic toxicity usually refers clinically to antimuscarinic effects. Central effects include confusion, agitation, hallucinations and picking at unseen objects; peripheral findings include dry mouth, reduced sweating, mydriasis, tachycardia, urinary retention and reduced gastrointestinal motility. Antihistamines, tricyclic antidepressants, bladder medicines, antiparkinsonian agents and some plants can contribute. The same substance may have other toxic actions: a tricyclic overdose can also produce sodium-channel blockade and serious arrhythmia.

The contrast between a sweaty patient with clonus and a dry patient with urinary retention is useful, but real cases may be incomplete or mixed. Temperature, hydration, age, comorbidity and co-ingestants alter the picture. Sympathomimetic poisoning, NMS, withdrawal, meningitis, encephalitis and heat illness remain important alternatives. A routine urine drug screen does not reliably identify all relevant agents or quantify the severity of poisoning.

Treatment begins before diagnostic certainty is perfect. Remove further exposure, provide a calm monitored environment and support airway, breathing and circulation. Manage excess muscular activity and temperature with emergency and critical-care teams when severe. Request poison-specific guidance to define observation periods, ECG surveillance, antidote indications and stopping criteria. Once the acute episode resolves, reconcile future medicines carefully and arrange psychosocial assessment when ingestion was intentional.

Key points

  • Serotonin toxicity combines a serotonergic exposure with neuromuscular, autonomic and mental-state changes, often developing soon after a new drug, dose change or interaction.
  • Clonus and hyperreflexia are important examination clues; severe rigidity can obscure these signs.
  • Antimuscarinic toxicity typically causes delirium with dry skin or mucosae, dilated pupils, urinary retention and reduced bowel activity.
  • Both syndromes can cause tachycardia, hyperthermia and agitation, so pupils or mental state alone do not distinguish them.
  • Reconcile prescribed, over-the-counter and recreational substances, including interactions and mixed overdoses.
  • Stop the relevant drugs and prioritise supportive care, temperature control, monitored treatment of agitation and complication surveillance.
  • Specific antagonists or antidotes require a confirmed clinical indication and toxicology advice; no single antidote is appropriate for every agitated overdose.

Aetiology

01

Serotonergic excess

Overdose, drug interactions or therapeutic changes involving serotonergic agents can produce a spectrum of toxicity, with combinations acting at different mechanisms increasing concern.

02

Muscarinic receptor blockade

Antihistamines, tricyclic antidepressants, bladder medicines and other agents may combine to cause central and peripheral antimuscarinic effects, particularly with overdose or high treatment burden.

Pathophysiology

  1. 1
    Neuromuscular activation

    Excess serotonergic activity can increase reflex and motor activity, producing tremor, clonus and rigidity that contribute to dangerous heat generation when severe.

  2. 2
    Central and peripheral blockade

    Reduced muscarinic activity disrupts attention and perception while decreasing secretions, sweating and gastrointestinal or bladder function, creating the characteristic dry delirious presentation.

  3. 3
    Multiple toxic mechanisms

    A single drug can act at several receptors or ion channels, so an antimuscarinic presentation may coexist with seizures, conduction delay or other life-threatening effects.

Clinical features and red flags

Neuromuscular excitation

Clonus, hyperreflexia and tremor in the setting of a serotonergic exposure strongly support serotonin toxicity rather than isolated psychiatric agitation.

Dry delirious state

Confusion with dry mucosae, reduced sweating, urinary retention and absent or reduced bowel sounds suggests an antimuscarinic pattern.

Severe temperature rise

Hyperthermia with rigidity or sustained muscular activity can progress rapidly to rhabdomyolysis, organ dysfunction and cardiovascular collapse.

Additional cardiotoxicity

A broad QRS complex or arrhythmia after an antimuscarinic medicine overdose may indicate sodium-channel blockade rather than a pure receptor toxidrome.

Red flags requiring action

  • Hyperthermia with sustained muscle activity or rigidity requires urgent cooling and airway-capable support; antipyretics alone do not correct the mechanism.
  • Wide-complex rhythm, syncope, seizure or hypotension after a suspected antimuscarinic overdose raises concern for additional cardiotoxic effects and needs immediate toxicological management.

Investigations

  1. 01
    Complete exposure timelineFirst step
    Why
    Identify causative medicines, interacting agents, formulation, dose changes and possible mixed ingestion.
    Interpretation and limitations
    Include cough remedies, analgesics, supplements, antihistamines and recreational drugs; uncertainty should prompt poison-specific expert advice rather than false reassurance.
  2. 02
    Neurological and peripheral examination
    Why
    Distinguish clonus and reflex changes from dry antimuscarinic features and other hyperthermic syndromes.
    Interpretation and limitations
    Document tone, clonus, reflexes, sweating, pupils, bowel sounds and bladder findings; severe rigidity or co-ingestion may blur the expected pattern.
  3. 03
    ECG and continuous monitoring when indicated
    Why
    Detect conduction abnormalities, QT effects and rhythm complications of the specific exposure.
    Interpretation and limitations
    QRS widening, arrhythmia or hypotension changes treatment priorities and may contraindicate proposed antidotes; repeat testing follows the poison's risk profile.
  4. 04
    Blood gas, electrolytes, renal function and CK
    Why
    Assess acidosis, electrolyte disturbance, muscle injury and organ consequences of severe toxicity.
    Interpretation and limitations
    Interpret trends with temperature, seizures, exertion and urine output; a normal early result does not exclude evolving systemic injury.

Differential diagnosis

01

Neuroleptic malignant syndrome

Dopamine-blocking exposure with generalised rigidity and systemic deterioration suggests NMS, although overlapping symptoms and mixed medication histories require careful clinical assessment.

02

Sympathomimetic poisoning

Agitation, tachycardia, hypertension and sweating can resemble serotonin toxicity, but the exposure history and pattern of neuromuscular findings help distinguish them.

03

Infection or neurological illness

Meningitis, encephalitis, seizures and other acute brain disorders can produce fever and altered behaviour, requiring parallel investigation when history or examination suggests them.

Management

01Initial recognitionStop exposure and establish severityFirst stepDrug history and new neurological or autonomic findings suggest serotonin or antimuscarinic toxicity.+
  1. 1Stop suspect medicines and assess ABCDE, glucose, core temperature, mental state, neuromuscular findings and the ECG.
  2. 2Identify all plausible exposures and consult the relevant TOXBASE entries, contacting NPIS when the syndrome, ingestion or treatment is uncertain.
  3. 3EscalationPlace the patient in a suitable monitored setting and agree observation, investigations and escalation thresholds with the emergency team.
02Physiological deteriorationControl the complications urgentlyHyperthermia, severe agitation, seizure, rigidity or cardiovascular instability is present or progressing.+
  1. 1Obtain critical-care and airway support, institute active temperature management and correct fluid or electrolyte problems according to physiology.

Complications

01

Heat-related organ injury

Severe hyperthermia and sustained muscle activity can damage several organs and rapidly progress to circulatory instability unless the physiological process is controlled.

02

Rhabdomyolysis and electrolyte disturbance

Muscle injury can cause rising CK, myoglobin-related renal injury and potassium abnormalities, requiring serial assessment rather than reliance on initial reassuring blood results.

03

Cardiorespiratory deterioration

Arrhythmia, seizures, aspiration and sedation-related hypoventilation may complicate the exposure or its treatment, supporting monitored care and timely airway expertise.

Monitoring and follow-up

  • Follow temperature, consciousness, respiratory state, heart rate, blood pressure and neuromuscular signs closely until a sustained improving trajectory is established.
  • Monitor urine output, renal function, electrolytes and CK when muscle injury or hyperthermia occurs, with repeat ECGs or continuous rhythm monitoring as the exposure requires.
  • Watch for retention, ileus and dehydration in antimuscarinic toxicity, providing supportive interventions and avoiding additional antimuscarinic medicines where possible.
  • Continue observation for a duration matched to the responsible agents and formulations; long half-lives or active metabolites can prolong toxicity after drugs are stopped.
  • Review the full medication list before restarting serotonergic treatment, and explain the cause and future interaction precautions to the patient and relevant prescribers.

Special situations

Sweating helps distinguish patterns

Reduced sweating supports peripheral muscarinic blockade, whereas diaphoresis often accompanies serotonin or sympathomimetic toxicity; mixed exposure can weaken the distinction.

A toxidrome is not a drug level

The pattern helps direct care, but it does not reveal all co-ingestants or replace ECG assessment and exposure-specific observation requirements.

Antipyretics miss the mechanism

Drug-related hyperthermia can arise from muscular activity and impaired heat loss rather than an ordinary fever set point, requiring active physiological management.

Resolution precedes restart decisions

Stopping the trigger is only the beginning; half-life, metabolites, interactions and the patient's psychiatric needs determine whether and when a serotonergic medicine can be resumed.

Common pitfalls

  1. 01

    Diagnosing serotonin toxicity solely because a patient taking an SSRI is anxious without examining for the relevant neuromuscular and autonomic findings.

  2. 02

    Missing urinary retention or ileus because attention is focused exclusively on agitation and hallucinations.

  3. 03

    Giving antimuscarinic or dopamine-blocking medicines empirically to a mixed toxidrome without considering their potential to worsen it.

  4. 04

    Treating severe drug-related hyperthermia only with paracetamol while sustained muscle activity and physiological deterioration continue.

  5. 05

    Using an antidote from memory without checking the causative agent, ECG, co-ingestions and current toxicology advice.

Content changes
Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
  • 05
    Targeted tests for alternative causes
    Why
    Investigate infection, endocrine disease, neurological pathology or other causes suggested by the clinical context.
    Interpretation and limitations
    Do not anchor on a medicine interaction when focal signs, meningism or another finding demands a parallel diagnostic pathway.
  • 2Use clinician-titrated sedation for dangerous muscular activity or seizures through the relevant emergency toxicology protocol, with respiratory monitoring and resuscitation capability.
  • 3Treat conduction abnormalities or other agent-specific effects through poison-specific guidance; avoid prolonged physical struggle that increases heat generation and muscle injury.
    • 03Specific therapy and recoveryUse antidotes only for the right syndromeSupportive treatment is established and specialist assessment identifies a role for a specific antagonist or antidote.+
    1. 1Consider an enteral serotonin antagonist for persistent serotonin toxicity only on specialist advice, recognising that severe illness still requires supportive critical care.
    2. 2Reserve physostigmine for selected antimuscarinic delirium after toxicology assessment, accounting for conduction disease, seizures and possible mixed or tricyclic poisoning.
    3. 3Before discharge or medicine restart, document the likely cause, interactions to avoid, resolution criteria and a supervised plan for future psychiatric treatment.
    Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
    An enteral serotonin antagonist sometimes used when clinically significant serotonin toxicity persists despite initial supportive measures.

    Cyproheptadine for serotonin toxicity

    NHS Lanarkshire's October 2025 adult guideline gives cyproheptadine 12 mg orally or by nasogastric tube initially, then 8 mg every six hours, with a stated maximum of 32 mg daily. This off-label regional regimen requires toxicology selection; confirm the initial 24-hour schedule including the loading dose, subsequent doses and stop point with NPIS or the treating toxicologist.

    Evidence for benefit is limited and treatment must be specialist-selected. This enteral medicine must not delay cooling, airway management or control of severe muscle activity. Sedation and antimuscarinic effects matter, especially with uncertain diagnosis or mixed ingestion.

    A specialist reversal option for carefully selected antimuscarinic delirium rather than routine treatment of any confused overdose.

    Physostigmine for selected antimuscarinic delirium

    Use only a toxicologist-authorised slow intravenous titration with the exact dose, administration rate, repeat interval and stopping criteria prescribed after reviewing the agent, ECG, seizure risk and clinical response. Continuous cardiac monitoring and immediate resuscitation facilities are required.

    Potential bradyarrhythmia and seizure risk require expert selection; avoid empirical administration where tricyclic or other cardiotoxic co-ingestion, QRS widening or an uncertain mixed syndrome is suspected.